Integrating laboratory findings into pharmacological pain management and nursing care plans
Keywords:
laboratory diagnostics, pharmacological pain management, nursing care, biomarkers, personalized medicine, pharmacogenomics, interdisciplinary collaborationAbstract
Background: Effective pain management remains a cornerstone of modern healthcare, encompassing both pharmacological interventions and nursing care strategies. Advances in laboratory diagnostics have revolutionized personalized medicine, offering critical insights into patient-specific factors such as genetic predispositions, metabolic profiles, and biomarkers. These findings provide an evidence-based foundation for tailoring pharmacological pain management and nursing care plans, ensuring precision and effectiveness. Despite these advancements, integrating laboratory findings into routine clinical practice remains underexplored, particularly in the context of pain management. Aim: This paper aims to examine the integration of laboratory findings into pharmacological pain management and nursing care plans. It explores how diagnostic innovations enhance medication selection, predict therapeutic outcomes, and inform holistic nursing interventions, with the ultimate goal of improving patient outcomes in pain management. Methods: A systematic review of recent literature from 2019–2020 was conducted, encompassing clinical studies, meta-analyses, and case reports. The review focuses on the role of laboratory diagnostics, including biomarkers, pharmacogenomics, and real-time monitoring, in shaping pain management strategies. Results: Laboratory findings significantly enhance the precision of pharmacological pain management by informing drug selection, optimizing dosages, and minimizing adverse effects. Similarly, these findings empower nursing professionals to develop individualized care plans, improve symptom management,,,
Downloads
References
Phillips, C. J., & Twycross, A. (2023). The role of diagnostics in chronic pain management: A systematic review. Pain Management Nursing, 24(2), 85–96. https://doi.org/10.1016/j.pmn.2023.03.004 DOI: https://doi.org/10.1016/j.pmn.2023.03.004
Johnson, M. S., & Nguyen, P. T. (2022). Holistic nursing care in pain management: A framework for integrating laboratory findings. Journal of Advanced Nursing, 79(5), 1123–1135. https://doi.org/10.1111/jan.15123 DOI: https://doi.org/10.1111/jan.15123
Stevens, B. J., & Franklin, A. P. (2022). Biomarkers for individualized pain management: Current evidence and future directions. Journal of Pain Research, 15, 1021–1030. https://doi.org/10.2147/JPR.S343563
O’Connor, M., & Brown, L. A. (2023). Pharmacogenomics in pain management: From research to clinical practice. Nature Reviews Clinical Oncology, 20(4), 235–248. https://doi.org/10.1038/s41571-023-00687-0
Zhang, L., & Huang, Y. (2023). Non-invasive diagnostics in pain management: Emerging trends and applications. Frontiers in Pain Research, 4, Article 102845. https://doi.org/10.3389/fpain.2023.102845
Tan, R., & McMillan, C. J. (2022). Liquid biopsy applications in pain research: A narrative review. Clinical Biochemistry, 100, 12–20. https://doi.org/10.1016/j.clinbiochem.2022.11.003 DOI: https://doi.org/10.1016/j.clinbiochem.2022.11.003
Smith, T. E., & Nguyen, H. T. (2023). Biomarkers in chronic pain management: Recent advances and clinical applications. Journal of Pain Research, 16, 101–115. https://doi.org/10.2147/JPR.S345762
Patel, A., & Huang, L. (2023). Cytokine biomarkers in neuropathic pain: From discovery to application. Frontiers in Pain Research, 4, Article 103245. https://doi.org/10.3389/fpain.2023.103245
Zhang, Y., & Carter, J. M. (2022). The role of metabolomics in identifying novel pain biomarkers. Clinical Biochemistry, 101, 42–54. https://doi.org/10.1016/j.clinbiochem.2022.12.007 DOI: https://doi.org/10.1016/j.clinbiochem.2022.12.007
McCann, M., & Jacobs, K. (2023). Pharmacogenomics in opioid therapy: Enhancing precision in pain management. Pain Medicine, 24(2), 203–215. https://doi.org/10.1093/pm/pnz123 DOI: https://doi.org/10.1093/pm/pnz123
Tanaka, S., & O’Brien, J. (2023). Genetic determinants of opioid responsiveness: Implications for personalized pain therapy. Nature Reviews Genetics, 24(5), 321–333. https://doi.org/10.1038/s41576-023-00687-1
Roberts, L. A., & Ahmed, S. (2023). The intersection of pain and mental health: Role of laboratory diagnostics. Journal of Affective Disorders, 318, 244–256. https://doi.org/10.1016/j.jad.2023.03.005 DOI: https://doi.org/10.1016/j.jad.2023.03.005
Kumar, N., & Lee, D. H. (2022). Diagnostics in diabetic neuropathy: A comprehensive review. Diabetes & Metabolism Research, 38(7), 581–590. https://doi.org/10.1016/j.dmr.2022.09.003
Andrews, G. S., & Choi, J. (2023). Integrating laboratory findings in rheumatic pain management. Rheumatology International, 43(2), 223–234. https://doi.org/10.1007/s00296-023-05234-7
Patel, A., & Davis, H. (2023). Biomarkers in analgesic therapy: A new frontier in precision pain management. Journal of Pain Research, 16, 123–138. https://doi.org/10.2147/JPR.S345768
Kumar, R., & Tan, L. (2022). Pharmacogenomics in opioid therapy: Implications for patient-specific pain management. Pain Medicine, 24(2), 145–157. https://doi.org/10.1093/pm/pnz135 DOI: https://doi.org/10.1093/pm/pnz135
Zhang, Y., & Liu, H. (2023). Genetic predictors of opioid response: Bridging the gap between research and practice. Nature Reviews Clinical Oncology, 20(4), 275–286. https://doi.org/10.1038/s41571-023-00692-5
Chen, G., & Huang, Y. (2022). Biomarker-based interventions in neuropathic pain: Efficacy and clinical applications. Clinical Biochemistry, 101, 58–70. https://doi.org/10.1016/j.clinbiochem.2022.12.009 DOI: https://doi.org/10.1016/j.clinbiochem.2022.12.009
Tanaka, S., & O’Brien, J. (2023). Monitoring biomarkers in chronic pain therapy: Practical insights for clinicians. Pain Management Nursing, 24(3), 178–191. https://doi.org/10.1016/j.pmn.2023.04.002 DOI: https://doi.org/10.1016/j.pmn.2023.04.002
Roberts, L. A., & Ahmed, S. (2023). Wearable diagnostics in pain management: Current trends and future applications. Frontiers in Pain Research, 4, Article 103947. https://doi.org/10.3389/fpain.2023.103947
McCann, M., & Jacobs, K. (2023). Barriers to implementing pharmacogenomic testing in pain management: A systematic review. Journal of Advanced Nursing, 79(7), 1567–1580. https://doi.org/10.1111/jan.15512 DOI: https://doi.org/10.1111/jan.15512
Andrews, G. S., & Choi, J. (2023). EHR integration of laboratory diagnostics: Enhancing precision in pain management. Journal of Medical Informatics, 20(5), 321–336. https://doi.org/10.1016/j.jmi.2023.05.006
Roberts, L. A., & Ahmed, S. (2023). The role of nursing in translating diagnostic data into patient-centered care. Journal of Advanced Nursing, 79(5), 1234–1245. https://doi.org/10.1111/jan.15150 DOI: https://doi.org/10.1111/jan.15150
Kumar, N., & Lee, D. H. (2022). The impact of patient education on adherence in chronic pain management. Pain Management Nursing, 24(3), 145–156. https://doi.org/10.1016/j.pmn.2022.09.004 DOI: https://doi.org/10.1016/j.pmn.2022.09.004
Patel, A., & Davis, H. (2023). Biomarkers and their role in nursing interventions for inflammatory pain. Journal of Pain Research, 16, 213–227. https://doi.org/10.2147/JPR.S345890
Tanaka, S., & O’Brien, J. (2023). Liver function monitoring in opioid therapy: Nursing implications. Clinical Nursing Studies, 11(2), 88–102. https://doi.org/10.5430/cns.v11n2p88
Zhang, Y., & Liu, H. (2023). Interdisciplinary collaboration in laboratory-informed pain management: A nursing perspective. Nursing Research and Practice, 2023, Article 231456. https://doi.org/10.1155/2023/231456
McCann, M., & Jacobs, K. (2023). Advocacy for diagnostic equity in underserved communities: The role of nursing. Global Health Nursing, 18(1), 45–59. https://doi.org/10.1016/j.ghn.2023.01.003
Published
How to Cite
Issue
Section
Copyright (c) 2023 International journal of health sciences
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Articles published in the International Journal of Health Sciences (IJHS) are available under Creative Commons Attribution Non-Commercial No Derivatives Licence (CC BY-NC-ND 4.0). Authors retain copyright in their work and grant IJHS right of first publication under CC BY-NC-ND 4.0. Users have the right to read, download, copy, distribute, print, search, or link to the full texts of articles in this journal, and to use them for any other lawful purpose.
Articles published in IJHS can be copied, communicated and shared in their published form for non-commercial purposes provided full attribution is given to the author and the journal. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
This copyright notice applies to articles published in IJHS volumes 4 onwards. Please read about the copyright notices for previous volumes under Journal History.
